Evidence map›Paper›PMID 38456086›Full record

ArticleThe Lancet regional health. Western Pacific2024

The return on investment for the prevention and treatment of childhood and adolescent overweight and obesity in China: a modelling study.

Guansheng Ma, Christina L Meyer, Angela Jackson-Morris, Suying Chang, Anuradha Narayan, Man Zhang, Daphne Wu, Youfa Wang, Zhenyu Yang, Huijun Wang and 2 more

Abstract read
In one paragraph

Article in The Lancet regional health. Western Pacific, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Guansheng MaDepartment of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing, China.
Christina L MeyerCenter for Global Noncommunicable Diseases, RTI International, Durham, NC, USA.
Angela Jackson-MorrisCenter for Global Noncommunicable Diseases, RTI International, Durham, NC, USA.
Suying ChangUNICEF China, Beijing, China.
Anuradha NarayanUNICEF China, Beijing, China.
Man ZhangDepartment of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing, China.
Daphne WuCenter for Global Noncommunicable Diseases, RTI International, Durham, NC, USA.
Youfa WangInternational Obesity and Metabolic Disease Research Center, Global Health Institute, School of Public Health, Xi'an Jiaotong University, Xi'an, Shannxi, China.
Zhenyu YangNational Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing, China.
Huijun WangNational Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing, China.
Li ZhaoDepartment of Health Policy and Management, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Rachel NugentCenter for Global Noncommunicable Diseases, RTI International, Durham, NC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The rapid increase in child and adolescent overweight and obesity (OAO) in China has a significant health and economic impact. This study undertook an investment case analysis to evaluate the health and economic impacts of child and adolescent OAO in China and the potential health and economic returns from implementing specific policies and interventions. Methods: The analysis estimates the reduction in mortality and morbidity from implementing a set of evidence-based interventions across China between 2025 and 2092 using a deterministic Markov cohort model. Modelled interventions were identified by literature review and expert recommendation and include fiscal and regulatory policies, eHealth breastfeeding promotion, school-based interventions, and nutritional counselling by physicians. The study applies a societal costing perspective to model the economic impact on healthcare cost savings, wages, and productivity during adulthood. By projecting and comparing the costs between a status quo scenario and an intervention scenario, the study estimates the return on investment (ROI) for interventions separately and in combination. Findings: Without intervention China will experience 3.3 billion disability-adjusted life years (DALYs) due its current levels of child and adolescent OAO and a lifetime economic impact of CNY 218 trillion (USD 31.6 trillion), or a lifetime CNY 2.5 million loss per affected child or adolescent (USD 350 thousand). National implementation of all five interventions would avert 179.4 million DALYs and result in CNY 13.1 trillion of benefits over the model cohort's lifetime. Implementing fiscal and regulatory policies had the strongest ROI, with benefits accruing at least 10 years after implementation. Scaling up China's current school-based interventions offers China significant health and economic gains, however, the ROI is lower than other modelled interventions. Interpretation: Effective prevention and treatment of child and adolescent OAO is critical to China's health and economic development. Multiple interventions offer a comprehensive approach to address the various factors that increase risk of child and adolescent OAO. Nonetheless, fiscal and regulatory policies offer the strongest health and economic gains. Funding: Funding was provided by UNICEF China.

Indexed as

Adolescent healthChild healthChinaEconomic evaluationHealth policyInvestment caseObesityOverweight

Identifiers

PMID38456086
PMCPMC10920044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.